Bioluminescence Resonance Energy Transfer ( BRET ) Technologies to Study GPCRs

Natasha Dale, Carl White, Liz Johnstone, Kevin Pfleger

Research output: Chapter in Book/Conference paperChapterpeer-review

Abstract

G protein-coupled receptors (GPCRs) represent a major target for the development of pharmaceuticals. As such, they are subject to extensive research to understand their function, as well as how their signaling is influenced by therapeutics. Bioluminescence Resonance Energy Transfer (BRET) is a biophysical technique that enables real-time monitoring of protein and small molecule proximity in live cells. BRET has seen widespread use as an important research tool to elucidate many aspects of GPCR pharmacology. Recently, multiple technological advances have furthered the scope and power of BRET techniques. New assay platforms such as NanoBRET have enabled the development of novel applications of the BRET technique, while the combination of BRET with newly developed biosensors has been shown to be a powerful research strategy. Here, we review recent BRET assay developments and their uses, demonstrating the rapidly expanding facets of GPCR pharmacology that can be studied utilizing BRET technologies. These tools will likely prove to be fundamental in furthering our understanding of GPCR function and pharmaceutical development.
Original languageEnglish
Title of host publicationGPCRs as Therapeutic Targets
EditorsAnnette Gilchrist
PublisherJohn Wiley & Sons
Chapter23
Volume1
ISBN (Electronic)9781119564782
ISBN (Print)9781119564744
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Bioluminescence Resonance Energy Transfer ( BRET ) Technologies to Study GPCRs'. Together they form a unique fingerprint.

Cite this